These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18785239)

  • 1. Mass spectrometry analysis of the influenza virus.
    Downard KM; Morrissey B; Schwahn AB
    Mass Spectrom Rev; 2009; 28(1):35-49. PubMed ID: 18785239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Williams TL; Luna L; Guo Z; Cox NJ; Pirkle JL; Donis RO; Barr JR
    Vaccine; 2008 May; 26(20):2510-20. PubMed ID: 18440105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtyping of the influenza virus by high resolution mass spectrometry.
    Schwahn AB; Wong JW; Downard KM
    Anal Chem; 2009 May; 81(9):3500-6. PubMed ID: 19402721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of a multiplex anti-influenza peptide immunoassay.
    Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
    J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characterisation of H3N2 subtypes of the influenza virus by mass spectrometry.
    Morrissey B; Streamer M; Downard KM
    J Virol Methods; 2007 Nov; 145(2):106-14. PubMed ID: 17588679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingerprinting a killer: surveillance of the influenza virus by mass spectrometry.
    Downard KM; Morrissey B
    Analyst; 2007 Jul; 132(7):611-4. PubMed ID: 17592578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain identification of commercial influenza vaccines by mass spectrometry.
    Creskey MC; Smith DG; Cyr TD
    Anal Biochem; 2010 Nov; 406(2):193-203. PubMed ID: 20667441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice.
    D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP
    Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.
    Getie-Kebtie M; Sultana I; Eichelberger M; Alterman M
    Influenza Other Respir Viruses; 2013 Jul; 7(4):521-30. PubMed ID: 22943763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope-based vaccine against influenza.
    Ben-Yedidia T; Arnon R
    Expert Rev Vaccines; 2007 Dec; 6(6):939-48. PubMed ID: 18034655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and quantitative detection of influenza virus proteins in commercial vaccines using two-dimensional high-performance liquid chromatography and fluorescence detection.
    García-Cañas V; Lorbetskie B; Bertrand D; Cyr TD; Girard M
    Anal Chem; 2007 Apr; 79(8):3164-72. PubMed ID: 17361989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic surveillance of the influenza virus by mass spectrometry.
    Kiselar JG; Downard KM
    Biochemistry; 1999 Oct; 38(43):14185-91. PubMed ID: 10571992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
    Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
    Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production.
    Schwarzer J; Rapp E; Reichl U
    Electrophoresis; 2008 Nov; 29(20):4203-14. PubMed ID: 18925582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of a type A influenza virus through comparison of hemagglutination inhibition and mass spectrometry immunoassays.
    Schwahn AB; Downard KM
    J Immunoassay Immunochem; 2009; 30(3):245-61. PubMed ID: 19591040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus.
    Chiu FF; Venkatesan N; Wu CR; Chou AH; Chen HW; Lian SP; Liu SJ; Huang CC; Lian WC; Chong P; Leng CH
    Biochem Biophys Res Commun; 2009 May; 383(1):27-31. PubMed ID: 19324009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
    Patel A; Tran K; Gray M; Li Y; Ao Z; Yao X; Kobasa D; Kobinger GP
    Vaccine; 2009 May; 27(23):3083-9. PubMed ID: 19428922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry analysis of influenza virus reassortant clones does not reveal an influence of other viral proteins on S-acylation of hemagglutinin.
    Serebryakova MV; Kordyukova LV; Rudneva IA; Kropotkina EA; Veit M; Baratova LA
    Arch Virol; 2013 Feb; 158(2):467-72. PubMed ID: 23065113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.